Deltagarlista/Participants list
Here is the participants list from our seminar on November 18.
Infrastructure for drug development in Stockholm – future technologies in imaging and radiopharmacy
Speakers
- Andreas Muranyi Scheutz, Director of Research and Innovation at Region Stockholm.
- Thuy Tran, Senior Scientist at Department of Oncology and Pathology, Karolinska Institutet. Head of Karolinska Theranostics Trial Center.
- Magnus Schou, Senior Director at AstraZeneca. Adjunct Professor in Medicinal Radiochemistry at Karolinska Institutet.
- Laurent Martarello, Chief Scientific Officer and Co-Founder at Sentonix Inc.
- Patrik Jarvoll, Head of Department at PRI, Preclinical Research and Imaging, Karolinska University Hospital.
- Andrea Varrone, Professor and Head of Division of Imaging Core Facilities at the Department of Clinical Neuroscience, Karolinska Institutet.
- Daniel Lundqvist, Professor at Department of Clinical Neuroscience, Karolinska Institutet. Director of Centre for Imaging Research (CIR).
Andreas Namslauer and Filippa Kull, Stockholm Science City (moderator)
Participants
- Adam Szulkin, Roche
- Anders Juréus, Regsmart LifeSciences AB
- Andreas Fasth, Nefro Avillion Clinical Development
- Angela Hoyer, Stiftelsen Flemingsberg Science
- Anki Nilsson, Celluminova AB
- Anna Frejd, SciLifeLab
- Anna Nordmark, Nordmark ClinPharm Consulting AB
- Anna Quigley, Affibody AB
- Anton Forsberg Morén, Karolinska Institutet
- Astrid Berg, Stockholm Science City
- Britta Stenson, Vectura
- Carla Carvalho, Truly Labs AB
- Carlos Mario Ayala Torres, Karolinska Institutet
- Cecilia Leideman Bäck, Karolinska Institutet
- Charlie Widberg, Invedo AB
- Christina Jägare, Stockholm Science City
- Christoph Pfeiffer, CIR - KI
- Dirk Weigelt, RISE Research Institutes of Sweden
- Emilia Palmér, PETMR unit, Karolinska University Hospital
- Erika Bellander, Karolinska Institutet
- Eva Backström Rydin, Affibody AB
- Evgenia Maria Krekoukia, Karolinska Institutet
- Fredrik Edlund, Bayer AB
- Fredrik Engströmer, Region Stockholm
- Fredrik Frejd, Affibody AB
- George Coleman, World Courier
- Gisela Finnman, Global Site & Study Operations
- Guido Wuerth, Affibody AB
- Henrik Ahlqvist, Independent Consultant
- Henrik Nordlander, Sciety AB
- Jan-Erik Nyström, TIRmed Pharma
- Jennifer Blinn, Karolinska Institutet
- Jenny Suhama, Bayer AB
- Johan Krohné, World Courier
- Johan Sandell, Novandi Chemistry AB
- Johan Staaf, Patent- och registreringsverket
- Jonas Gårding, Elekta
- Jonas Rehn, Elekta
- Julie Bianchi, Karolinska Institutet
- Jörgen Rosén, Karolinska Institutet
- Kajsa Liljegren, Stockholm Science City
- Karin Dillner Bergstedt, Affibody AB
- Laura Fagerhed, Novartis
- Lovisa Johansson, Karolinska Institutet
- Magnus Lejelöv, STUNS
- Magnus Persson, Stockholm Science Citys styrelse
- Malin Warolen, JnJ Innovative Medicine
- Maria Wanderoy, Wanderoy Management
- Mariana Malihiolzakerni, Four Service
- Marie Österlund, Affibody AB
- Martin Bolin, Karolinska Institutet
- Matilda Bäckberg, Legado Bioresearch AB
- Mats Ferm, KI Innovations
- Mattias Mineur, World Courier
- Mina Mousaeian, Stockholm Science City
- Nancy Stratman, Sentonix Pharma
- Natasha Bank, Flemingsberg Science Foundation
- Nicki Jennings, Sentonix Pharma
- Nico Dantuma, Karolinska Institutet
- Ola Björkman, 59 Degrees North Communications
- Olof Zachrisson, BioArctic AB
- Oskar Frisell, IHE - Institutet för Hälso- och Sjukvårdsekonomi
- Patrik Blomquist, KI Innovations
- Per Ragnarsson, Bayer AB
- Quentin Glaziou, Karolinska Institutet
- Raymond Josephsson, University - Zewail City of Science, Technology and Innovation
- Renske Altena, Docrates Cancersjukhus
- Rolf Lewensohn, Karolinska Institutet
- Rutger Smith, AB Kulissen
- Setareh Arya, ImmunoIVD
- Simon Martarello, Karolinska Institutet
- Stefano Pietra, University of Cambridge
- Susanne Fagerstedt Bühler, Med Consulting
- Tanja Laine, Capgemini
- Tonyak Riba, Stockholm University
- Tor Sander, Sciety AB
- Try Palm, TAP
- Ulrika Randén, Legado Bioresearch AB
- Vasco Sousa, Karolinska Institutet, Center for Imaging Research
- Xinxin Yan, Karolinska Institutet
- Ylva Williams, Stockholm Science City